9:10am ET
Health and Healthcare
Why AbbVie Earnings Failed to Impress Investors
AbbVie reported its first-quarter financial results and guidance before the markets opened on Thursday.
Chris Lange
Companies
/Healthcare
Abbvie Inc
$264.02
▲ $1.51 (+0.58%) today
Markets open · 9:39am ET
ABBV Coverage
Page 35 Chris Lange 9:15am ET
Health and Healthcare
Major Pharma Short Interest Remains Mixed, With 1 Massive Drop
The April 15 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks short interest was mixed.
6:57am ET
Special Report
The World’s 15 Top Selling Drugs
Attaining a certain drug can mean the difference between life and death for millions of Americans. These essential products also help generate billions for drug manufacturers. Pharmaceutical companies generate an estimated $300…
8:25am ET
Investing
2 Cheap Pharmaceuticals Highlight Jefferies Franchise Picks Dividend Stocks to Buy
These four Jefferies Franchise Picks are rated Buy and pay the highest dividends. They make good sense for investors now.
9:50am ET
Health and Healthcare
Short Sellers Become More Selective in Major Pharma
The March 31 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks short interest was mixed.
8:35am ET
Investing
4 Jefferies Franchise Picks With Big Dividends Are Solid Q2 Buys
Now all investor eyes turn to first-quarter earnings results. With interest rates still very low, investors looking to add capital should still focus on top dividend-paying stocks.
11:05am ET
Health and Healthcare
Top Dividend-Paying Pharmaceutical Stocks Rated Buy by Analysts
Long-term growth investors looking for a degree of safety and value should consider some of these outstanding companies. While the sentiment may be less than stellar now, massive drug pricing changes anytime…
9:25am ET
Health and Healthcare
Jefferies Top Drug Stocks for the Rest of 2016
For the most part, Jefferies maintained its list of top companies in the health care sector, but it also made a couple additions and updated its price target information.
8:40am ET
Health and Healthcare
Major Pharma Short Interest Takes a Small Step Back
The February 29 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks short interest decreased.
10:10am ET
Investing
Large Cap Blue Chips Dominate Jefferies Top Value Stocks to Buy
In a recent research report, Jefferiesfocused on some large cap stocks that are still trading way below their 52-week highs.
8:45am ET
Investing
Top Analyst Upgrades and Downgrades: Enbridge, Micron, Sun Life, Starbucks, Stratasys, Wynn and Many More
The top analyst upgrades, downgrades and initiations seen from Monday, March 7, include Enbridge, Micron Technology, Sun Life Financial, Starbucks, Stratasys and Wynn Resorts.
8:50am ET
Investing
Top Analyst Upgrades and Downgrades: American Water, Autodesk, Kraft Heinz, Palo Alto, Toyota, Vipshop and More
The top analyst upgrades, downgrades and initiations seen from Friday, February 26, include American Water Works, Autodesk, Kraft Heinz, Palo Alto Networks, Toyota and Vipshop.
8:10am ET
Health and Healthcare
Short Sellers Increase Bets in Major Pharma
The February 12 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short interest increased.
9:50am ET
Investing
Top Hedge Funds Love These 5 Big Blue-Chip Dividend-Paying Stocks
These stocks make good sense for long-term patient investors that have a growth and income total return bias in their portfolios.
8:55am ET
Investing
Top Analyst Upgrades and Downgrades: Annaly Capital, Barrick, Cheniere, Fitbit, Dean Foods, Groupon, SolarCity, Twitter, US Steel and More
The top analyst upgrades, downgrades and initiations seen on Tuesday, February 23, include Annaly Capital Management, Barrick Gold, Cheniere Energy, Fitbit, Dean Foods, Groupon, SolarCity, Twitter and U.S. Steel.